Gyeonggi-do, South Korea

Jaekeol Rhee




Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Hwaseong-si, KR (2017 - 2018)
  • Gyeonggi-do, KR (2015 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jaekeol Rhee: Innovator in Metabolic Disease Treatment

Introduction

Jaekeol Rhee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of metabolic diseases. With a total of 4 patents to his name, Rhee's work focuses on innovative compositions that aim to improve health outcomes for patients suffering from various metabolic disorders.

Latest Patents

Rhee's latest patents include a composite preparation that contains a novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative. This composition is designed for preventing or treating metabolic diseases. The invention highlights the effectiveness of combining this derivative with other active ingredients, such as DPPIV inhibitors and SGLT2 inhibitors, to achieve remarkable blood sugar reduction in diabetic animal models. Another notable patent involves the preparation method of the same derivative, which has shown excellent activity in activating GPR40 protein and promoting insulin secretion without toxicity when co-administered with other drugs. This innovation holds promise for treating conditions like obesity, type I and type II diabetes, and other related metabolic disorders.

Career Highlights

Jaekeol Rhee is currently associated with Hyundai Pharm Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the realm of metabolic disease treatment.

Collaborations

Rhee collaborates with notable colleagues, including Jin Wook Yang and Han Kyu Lee. Their combined expertise contributes to the innovative research and development efforts at Hyundai Pharm Co., Ltd.

Conclusion

Jaekeol Rhee's contributions to the field of metabolic disease treatment through his innovative patents demonstrate his commitment to improving patient health. His work continues to pave the way for advancements in pharmaceutical compositions aimed at combating metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…